Leerink Partners Issues Positive Forecast for Tenet Healthcare (NYSE:THC) Stock Price

Tenet Healthcare (NYSE:THC) had its target price boosted by investment analysts at Leerink Partners from $255.00 to $264.00 in a research note issued on Friday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Leerink Partners’ price objective indicates a potential upside of 15.00% from the company’s current price.

A number of other equities research analysts also recently weighed in on THC. Guggenheim raised their price objective on Tenet Healthcare from $257.00 to $271.00 and gave the company a “buy” rating in a research report on Friday, February 13th. Jefferies Financial Group upped their target price on Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. TD Cowen reissued a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Wall Street Zen raised shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 31st. Finally, Cantor Fitzgerald boosted their target price on shares of Tenet Healthcare from $190.00 to $245.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 29th. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $247.67.

Tenet Healthcare Stock Up 0.6%

THC traded up $1.48 during trading on Friday, reaching $229.56. The stock had a trading volume of 1,007,566 shares, compared to its average volume of 1,071,737. The stock’s 50 day moving average is $201.26 and its two-hundred day moving average is $196.69. Tenet Healthcare has a one year low of $109.82 and a one year high of $235.77. The company has a market capitalization of $19.96 billion, a price-to-earnings ratio of 14.82, a P/E/G ratio of 1.14 and a beta of 1.44. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. The firm had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The company’s quarterly revenue was up 8.9% on a year-over-year basis. During the same period in the prior year, the company posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, analysts expect that Tenet Healthcare will post 12.24 earnings per share for the current year.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. The trade was a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.81% of the company’s stock.

Institutional Trading of Tenet Healthcare

Several institutional investors have recently added to or reduced their stakes in the stock. Dorsey Wright & Associates acquired a new stake in shares of Tenet Healthcare in the fourth quarter valued at $10,750,000. Corient Private Wealth LLC raised its holdings in shares of Tenet Healthcare by 1,103.6% in the 4th quarter. Corient Private Wealth LLC now owns 45,847 shares of the company’s stock valued at $9,111,000 after purchasing an additional 42,038 shares in the last quarter. Mercer Global Advisors Inc. ADV lifted its position in shares of Tenet Healthcare by 24.4% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 42,180 shares of the company’s stock worth $8,382,000 after purchasing an additional 8,273 shares during the last quarter. Vident Advisory LLC lifted its stake in Tenet Healthcare by 6.3% during the fourth quarter. Vident Advisory LLC now owns 2,185 shares of the company’s stock worth $434,000 after purchasing an additional 129 shares during the last quarter. Finally, State of Tennessee Department of Treasury raised its holdings in Tenet Healthcare by 0.6% during the fourth quarter. State of Tennessee Department of Treasury now owns 37,491 shares of the company’s stock worth $7,096,000 after purchasing an additional 223 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.